Reactogenicity, Safety and Immunogenicity of an Universal Influenza Vaccine Uniflu
Reactogenicity, Safety and Immunogenicity of an Recombinant Universal Influenza Vaccine Uniflu in Healthy Volunteers From 18 to 60 Years Old